Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Paul Goldenheim"'
Autor:
Ronald D. Fitzmartin, Robert F. Reder, Paul Goldenheim, David P. Benziger, Robert F. Kaiko, Brian E. Burke
Publikováno v:
Clinical Pharmacology & Therapeutics. 59:52-61
Plasma concentrations of oxycodone, oxymorphone, and noroxycodone were determined after administration of 20 mg oral controlled-release oxycodone tablets to four subject groups: young (aged 21 to 45 years) men, elderly (aged 65 to 79 years) men, youn
Publikováno v:
The Journal of Clinical Pharmacology. 35:499-504
Twenty-three normal volunteers who received morphine sulphate (MS Contin) with naltrexone completed this randomized, analytically blinded, two-way crossover comparison of the bioavailability of one 200-mg oral controlled-release morphine sulfate tabl
Autor:
James Komorowski, Jeanette Mitchell, Tom P Barden, Robert F. Kaiko, Paul Goldenheim, Gail B Cissell, Saul S Bloomfield, Ronald D. Fitzmartin, R. Grandy
Publikováno v:
Clinical Pharmacology and Therapeutics. 53:469-478
MS Contin tablets and Oramorph SR tablets are two forms of oral controlled-release morphine sulfate available for the alleviation of pain. Our objective was to compare their analgesic effects in a relative potency assay. In this study, 151 patients u
Controlled-Release Morphine Bioavailability (MS Contin® Tablets) in the Presence and Absence of Food
Publikováno v:
The Hospice Journal. 6:17-30
The bioavailability of a single, orally administered, 30-mg controlled-release morphine tablet (MS Contin Tablet; The Purdue Frederick Company, Norwalk, Conn.) was compared after fasting or a high fat meal in this single dose, randomized, crossover s
Autor:
Piqué-Buisan, Joel1,2 (AUTHOR), Baños, Josep-E1 (AUTHOR), Cambra-Badii, Irene1,3,4 (AUTHOR) irene.cambra@uvic.cat
Publikováno v:
PLoS ONE. 4/4/2024, Vol. 19 Issue 4, p1-20. 20p.
Autor:
Abraham Sunshine, Robert F. Reder, Ronald D. Fitzmartin, Paul Goldenheim, Juana Rivera, Robert F. Kaiko, Ariel Colon, Nancy Z. Olson
Publikováno v:
Journal of clinical pharmacology. 36(7)
The efficacy and safety of graded doses (10, 20, and 30 mg) of controlled-release (CR) oxycodone was compared with that of immediate-release (IR) oxycodone (15 mg), immediate-release oxycodone 10 mg in combination with acetaminophen 650 mg (APAP), an
Autor:
Liane K. Schein, Paul Goldenheim
Publikováno v:
Annals of the New York Academy of Sciences. 618
1. Asthma and COPD worsen at night and in the early morning, due to various circadian influences. 2. Uninterrupted sleep, stable lung function over 24 h, and reduced and stable airways responsiveness are primary therapeutic goals in asthma and COPD.
Publikováno v:
Journal of general internal medicine. 5(2)
The diagnostic strategy for asymptomatic patients with persistent bilateral bilar adenopathy often involves invasive procedures. The authors used Bayesian analysis to: 1) estimate the relative prevalences of diseases causing bilateral bilar adenopath
Publikováno v:
The Hospice journal. 6(4)
The analgesic efficacy of oral controlled-release morphine (MS Contin Tablets; MSC) and its influence on quality of life, including parameters of nighttime sleep and daytime functioning, were evaluated in this open-label, sequential study in cancer p
Publikováno v:
European Journal of Pharmacology. 183:2269-2270